The Haloperidol Injection, cataloged under National Stock Number 6505-01-693-8815, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-693-8815 |
| Primary Part Number | NDC63323-0474-10 |
| Item Name | Haloperidol Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR |
| Primary Container Content Quantity | 10.0 MILLILITERS |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0474-10 PRIMARY | Fresenius Kabi, Llc (USA) |
| NDC00143-9502-01 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC63323-0474-10 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM216894 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1590738 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-693-8815 is a Haloperidol Injection, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-693-8815 has 3 manufacturer part numbers on file: NDC63323-0474-10 (Fresenius Kabi, Llc), NDC00143-9502-01 (Hikma Pharmaceuticals Usa Inc.), NDC63323-0474-10 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC63323-0474-10: Administration: INTRAMUSCULAR; Primary Container Content Quantity: 10.0 MILLILITERS; Primary Container Type: VIAL, MULTIPLE DOSE; Special Features: INDICATED FOR USE IN THE TREATMENT OF SCHIZOPHRENIA; HALOPERIDOL LACTATE5MG/ML, 10ML MULTIDOSE VIAL FOR INTRAMUSCULAR INJECTION; USED TO TREAT CERTAIN MENTAL/MOOD DISORDERS; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); DO NOT FREEZE; PROTECT FROM LIGHT.. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.